{
  "cik": 1799191,
  "cik_padded": "0001799191",
  "entityName": "Oncology Institute, Inc.",
  "fiscal_years": [
    {
      "accn": "0001799191-26-000007",
      "filed": "2026-03-12",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3200000.0,
        "eps_diluted": -0.54,
        "free_cash_flow": -27787000.0,
        "net_income": -60606000.0,
        "operating_cash_flow": -24587000.0,
        "operating_income": -36083000.0,
        "revenue": 502729000.0,
        "stockholders_equity": -15720000.0,
        "total_assets": 164656000.0,
        "total_liabilities": 180376000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "net_margin": -0.12055401617969125,
        "operating_margin": -0.0717742561101508,
        "revenue_growth_yoy": 0.2778690024706923,
        "roa_avg2y": -0.359281863101078,
        "roa_period_end": -0.3680764745894471,
        "roe_avg2y": 9.991921523369879
      }
    },
    {
      "accn": "0001799191-26-000007",
      "filed": "2026-03-12",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 3789000.0,
        "eps_diluted": -0.71,
        "free_cash_flow": -30327000.0,
        "net_income": -64663000.0,
        "operating_cash_flow": -26538000.0,
        "operating_income": -60118000.0,
        "revenue": 393412000.0,
        "stockholders_equity": 3589000.0,
        "total_assets": 172717000.0,
        "total_liabilities": 169128000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 47.123989969350795,
        "net_margin": -0.16436458471017662,
        "operating_margin": -0.15281181051925208,
        "revenue_growth_yoy": 0.21333954274470376,
        "roa_avg2y": -0.3385878515120812,
        "roa_period_end": -0.3743870030164952,
        "roe_avg2y": -2.133599498465701
      }
    },
    {
      "accn": "0001799191-26-000007",
      "filed": "2026-03-12",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 1019000.0,
        "capex": 4567000.0,
        "eps_diluted": -0.92,
        "free_cash_flow": -40882000.0,
        "net_income": -83068000.0,
        "operating_cash_flow": -36315000.0,
        "operating_income": -77018000.0,
        "revenue": 324239000.0,
        "stockholders_equity": 57025000.0,
        "total_assets": 209240000.0,
        "total_liabilities": 152215000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 2.669267864971504,
        "net_margin": -0.25619373363475706,
        "operating_margin": -0.23753465807629556,
        "revenue_growth_yoy": 0.28420131256361814,
        "roa_avg2y": -0.35280152047652924,
        "roa_period_end": -0.3969986618237431,
        "roe_avg2y": -0.9219533851276359
      }
    },
    {
      "accn": "0001799191-25-000014",
      "filed": "2025-03-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 9000000.0,
        "capex": 5529000.0,
        "eps_diluted": -0.21,
        "free_cash_flow": -67285000.0,
        "net_income": 152000.0,
        "operating_cash_flow": -61756000.0,
        "operating_income": -81951000.0,
        "revenue": 252483000.0,
        "stockholders_equity": 123175000.0,
        "total_assets": 261665000.0,
        "total_liabilities": 138490000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 1.1243352953115486,
        "net_margin": 0.0006020207301085618,
        "operating_margin": -0.32458026877057067,
        "revenue_growth_yoy": 0.24374024029201538,
        "roa_avg2y": 0.0006536172554955451,
        "roa_period_end": 0.0005808954197160491,
        "roe_avg2y": 0.0013372394802361283
      }
    },
    {
      "accn": "0001628280-24-013444",
      "filed": "2024-03-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 2847000.0,
        "eps_diluted": -0.16,
        "free_cash_flow": -35527000.0,
        "net_income": -10927000.0,
        "operating_cash_flow": -32680000.0,
        "operating_income": -45858000.0,
        "revenue": 203003000.0,
        "stockholders_equity": 104159000.0,
        "total_assets": 203439000.0,
        "total_liabilities": 99280000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 0.9531581524400196,
        "net_margin": -0.0538267907370827,
        "operating_margin": -0.225898139436363,
        "revenue_growth_yoy": 0.0825960589819481,
        "roa_avg2y": -0.08120299634374721,
        "roa_period_end": -0.05371143192799807,
        "roe_avg2y": -0.1652351429003478
      }
    },
    {
      "accn": "0001628280-23-008315",
      "filed": "2023-03-16",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1194000.0,
        "eps_diluted": -0.24,
        "free_cash_flow": -686000.0,
        "net_income": -14322000.0,
        "operating_cash_flow": 508000.0,
        "operating_income": -8197000.0,
        "revenue": 187515000.0,
        "stockholders_equity": 28101000.0,
        "total_assets": 65689000.0,
        "total_liabilities": 37588000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "leverage": 1.3376036439984342,
        "net_margin": -0.0763778897688185,
        "operating_margin": -0.04371383622643522,
        "roa_avg2y": -0.43572308675215626,
        "roa_period_end": -0.21802737140160453,
        "roe_avg2y": -0.4073205068043172
      }
    },
    {
      "accn": "0001628280-22-005868",
      "filed": "2022-03-11",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 42222000.0,
        "total_assets": 50000.0,
        "total_liabilities": 27300.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio"
      },
      "ratios": {
        "leverage": 0.0006465823504334233
      }
    }
  ],
  "latest_filing": {
    "accn": "0001799191-26-000007",
    "filed": "2026-03-12",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "8011",
  "sic_description": "Services-Offices & Clinics of  Doctors of  Medicine",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001799191.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001799191.json"
  },
  "ticker": "TOI"
}